---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-009274"
form_type: "8-K"
ticker: "FENC"
cik: "0001211583"
company_name: "FENNEC PHARMACEUTICALS INC."
filed_at: "2022-01-31T23:59:59+00:00"
generated_at: "2026-06-27T13:26:30.068843+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Fennec amends loan agreement with Bridge Bank; sets PEDMARK NDA resubmission and approval milestones

## Summary
- Third Amendment to 2019 Loan & Security Agreement with Bridge Bank (Western Alliance Bank) dated Jan 27, 2022.
- Defines 'Resubmission Event': resubmission of PEDMARK NDA to FDA on or before March 31, 2022.
- Defines 'Approval Event': receipt of final NDA approval for PEDMARK on or before September 30, 2022.
- Second Draw Period commences upon Approval Event; proceeds for commercial readiness prior to potential PEDMARK approval.

## SEC filing metadata
- accession: 0001104659-22-009274
- form_type: 8-K
- ticker: FENC
- cik: 0001211583
- company_name: FENNEC PHARMACEUTICALS INC.
- filed_at: 2022-01-31T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1211583/000110465922009274/0001104659-22-009274-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1211583/000110465922009274/tm224898d2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-009274
- JSON: https://secwatch.observer/filing/0001104659-22-009274.json
- Plain text: https://secwatch.observer/filing/0001104659-22-009274.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.